A randomized control trial to assess the efficacy and safety of ivermectin in the treatment of mild to moderate COVID 19 patients - Trial SLCTR_2021_020
Access comprehensive clinical trial information for SLCTR_2021_020 through Pure Global AI's free database. This Phase 2 trial is sponsored by Dr Ananda Wijewickrama and is currently Recruiting. The study focuses on COVID-19.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Sri Lanka Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
SLCTR_2021_020
Phase 2
Recruiting
Trial Details
Sri Lanka Clinical Trials Registry • SLCTR_2021_020
A randomized control trial to assess the efficacy and safety of ivermectin in the treatment of mild to moderate COVID 19 patients
Efficacy and safety of oral ivermectin in the treatment of COVID-19 patients: A randomized double-blind controlled clinical trial
Study Focus
Interventional
Sponsor & Location
Dr Ananda Wijewickrama
Sri Lanka
Timeline & Enrollment
Phase 2
Jul 29, 2021
N/A
ICD-10 Classifications
COVID-19, virus identified
COVID-19, virus not identified
Coronavirus infection, unspecified site
Viral infection, unspecified
Rift Valley fever
Data Source
Sri Lanka Clinical Trials Registry
SLCTR_2021_020
Non-Device Trial